Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer-Reference-Cited by-同舟云学术

Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer

Published:2020-03 Issue: Volume:32 Page:2-7
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Petrioli Roberto,Marrelli Daniele,Roviello Franco,D'Ignazio Alessia,Torre Pamela,Chirra Martina,Savelli Vinno,Ambrosio Maria Raffaella,Francini Guido,Calomino Natale,Farsi Marco,Vernillo Remo,Francini Edoardo

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference26 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

2. Cancer statistics;Siegel;CA A Cancer J. Clin.,2019

3. Pathological features as predictors of recurrence after radical resection of gastric cancer;Buzzoni;Br. J. Surg.,2006

4. The patterns and timing of recurrence after curative resection for gastric cancer in China;Liu;World J. Surg. Oncol.,2016

5. MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N. Engl. J. Med.,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Immunotherapy in the Management of Esophageal Cancer in Patients Treated with Neoadjuvant Chemoradiation: An Analysis of the National Cancer Database;Cancers;2024-07-04

2. Postoperative Radiotherapy in Curatively Resected Esophageal Squamous Cell Carcinoma With Occult Recurrent Laryngeal Nerve Lymph Node Metastasis;Cancer Control;2024-01

3. Analysis of risk factors affecting long-term survival in elderly patients with advanced gastric cancer;Aging Clinical and Experimental Research;2023-08-25

4. Impact of the Interval between Neoadjuvant Chemotherapy and Gastrectomy on Pathological Response and Survival Outcomes for Patients with Locally Advanced Gastric Cancer: A Meta-analysis;Euroasian Journal of Hepato-Gastroenterology;2023-03-10

5. Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases;Molecules;2022-04-11